Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model

Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model

Nicotinamide riboside (NR), a precursor of nicotinamide adenine dinucleotide (NAD<sup>+</sup>), has been studied to support human health against metabolic stress, cardiovascular disease, and neurodegenerative disease. In the present study, we investigated the effects of oral NR on axonal...

Full description

Bibliographic Details
Main Authors: Ibuki Arizono, Naoki Fujita, Chihiro Tsukahara, Kana Sase, Reio Sekine, Tatsuya Jujo, Mizuki Otsubo, Naoto Tokuda, Yasushi Kitaoka
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Current Issues in Molecular Biology
Subjects:
nicotinamide riboside
p-AMPK
glaucoma
optic nerve
RGC
Online Access:https://www.mdpi.com/1467-3045/45/9/449

Internet

https://www.mdpi.com/1467-3045/45/9/449

Similar Items